InvestorsHub Logo
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

Re: None

Sunday, 05/06/2012 10:25:27 AM

Sunday, May 06, 2012 10:25:27 AM

Post# of 53906
REGN FDA play this week

5/8/2012 REGN Regeneron Pharmaceuticals
Arcalyst (sBLA) FDA panel to review Arcalyst for addnl indication in preventing gout flares in patients initiating uric acid-lowering therapy


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.